Nektar Therapeutics | NKTR - Bienes





Bienes Cambio Fecha
Agios Pharmaceuticals USD 1.18B 112.24M 2026-03
ALKERMES USD 4.26B 1.77B 2026-03
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Amgen USD 92.5B 1.92B 2026-03
Baxter International USD 19.85B 209M 2026-03
BioCryst Pharmaceuticals USD 514.16M 67.73M 2025-12
Biogen USD 29.48B 43.6M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Cara Therapeutics USD 39.02M 4.73M 2025-09
Cipla INR 401.64B 27.77B 2025-09
Dr.Reddys Laboratories INR 562.9B 20.89B 2025-12
Eisai JPY 1.49T 48.22B 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
Esperion Therapeutics USD 465.89M 101.87M 2025-12
Exelixis USD 2.84B 20.87M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
Grifols EUR 23.15B 142.7M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Incyte USD 7.34B 381.14M 2026-03
Ionis Pharmaceuticals USD 3.45B 74M 2026-03
Ironwood Pharmaceuticals USD 396.06M 53.12M 2025-09
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
MacroGenics USD 256.85M 13.92M 2025-12
Merck USD 128.68B 8.18B 2026-03
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Neurocrine Biosciences USD 4.91B 274.7M 2026-03
Novartis USD 118.53B 7.58B 2026-03
Pfizer USD 207.62B 542M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
Takeda JPY 15.41T 938.47B 2025-12
Teva Pharmaceutical Industries USD 40.04B 708M 2026-03
Xencor USD 875.5M 6.68M 2025-12